Epidemiologic characteristics and natural history of HIV-1 natural viral suppressors

Journal of Acquired Immune Deficiency Syndromes

Volumn 50, Issue 4, 2009, Pages 403-408

  Sajadi, Mohammad M ^a,c   Constantine, Neil T ^a   Mann, Dean L ^a   Charurat, Manhattan ^a   Dadzan, Elham ^a   Kadlecik, Peter ^b   Redfield, Robert R ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b Chase Brexton Health Services   (United States)

^c INSTITUTE OF HUMAN VIROLOGY   (United States)

Author keywords

Elite controller; Elite suppressor; HIV natural viral suppressor; Natural history

Indexed keywords

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; SURVIVAL RATE; SURVIVAL TIME; VIRUS IMMUNITY; VIRUS LOAD; VIRUS REPLICATION; ACQUIRED IMMUNE DEFICIENCY SYNDROME; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; INCIDENCE; MIDDLE AGED; MORTALITY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; CD4 LYMPHOCYTE COUNT; FEMALE; HIV-1; HUMANS; INCIDENCE; MALE; MIDDLE AGED;

EID: 64249132925     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181945f1e     Document Type: Article

References (22)

1. MM Sajadi, A Heredia, N Le, et al. HIV-1 natural viral suppressors: control of viral replication in the absence of therapy. AIDS. 2007;21:517-519.
2. Candotti D, Costagliola D, Joberty C, et al. Status of long-term asymptomatic HIV-1 infection correlates with viral load but not with virus replication properties and cell tropism. French ALT Study Group. J Med Virol. 1999;58:256-263.
3. Pantaleo G, Menzo S, Vaccarezza M, et al. Studies in subjects with longterm nonprogressive human immunodeficiency virus infection. N Engl J Med. 1995;332:209-216.
4. Cao Y, Qin L, Zhang L, et al. Virologie and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N Engl J Med. 1995;332:201-208.
5. Ashton LJ, Carr A, Cunningham PH, et al. Predictors of progression in long-term nonprogressors. Australian Long-Term Nonprogressor Study Group. AIDS Res Hum Retroviruses. 1998;14:117-121.
6. Kloosterboer N, Groeneveld P, Jansen C, et al. Natural controlled HIV infection: preserved HIV-specific immunity despite undetectable replication competent virus. Virology. 200515;339:70-80.
7. Lambotte O, Boufassa F, Madec Y, et al. HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication. Clin Infect Dis. 2005;41:1053-1056.
8. Pereyra F, Addo MM, Kaufmann DE, et al. Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy. J Infect Dis. 2008;197:563-571.
9. Bailey JR, Lassen KG, Yang HC, et al. Neutralizing antibodies do not mediate suppression of human immunodeficiency virus type 1 in elite suppressors or selection of plasma virus variants in patients on highly active antiretroviral therapy. J Virol. 2006;80:4758-4770.
10. Bailey JR, Williams TM, Siliciano RF, et al. Maintenance of viral suppression in HIV-1-infected HLA-B*57+ elite suppressors despite CTL escape mutations. J Exp Med. 2006;203:1357-1369.
11. Wei M, Hong K, Huang H, et al. Biased G-to-A hypermutation in HIV-1 proviral DNA from a long-term non-progressor. AIDS. 2004; 18: 1863-1865.
12. + T cell depletion in an untreated HIV type 1-infected human leukocyte antigen-B*5801-positive patient with an undetectable viral load. Clin Infect Dis. 2008; 46:e78-e82.
13. Blankson JN, Bailey JR, Thayol S, et al. Isolation and characterization of replication-competent human immunodeficiency virus type 1 from a subset of elite suppressors. J Virol. 2007;81:2508-2518.
14. Han Y, Lai J, Barditch-Crovo P, et al. The role of protective HCP5 and HLA-C associated polymorphisms in the control of HIV-1 replication in a subset of elite suppressors. AIDS. 2008;22:541-544.
15. Wu L, Paxton W, Kassam N, et al. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1 in vitro. J Exp Med. 1997;185:1681-1691.
16. Migueles SA, Sabbaghian MS, Shupert WL, et al. HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIVinfected long term nonprogressors. Proc Natl Acad Sci USA. 2000;97: 2709-2714.
17. Mori M, Beatty PG, Graves M, et al. HLA gene and haplotype frequencies in the North American population: the National Marrow Donor Program Donor Registry. Transplantation. 1997;64:1017-1027.
18. Mann DL, Carrington M, Winkler C, et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science. 1996;273:1856-1862.
19. Vento S, Lanzafame M, Malena M, et al. Can we really identify HIV-1 long-term nonprogressors? J Acquir Immune Defic Syndr. 2004;37: 1218-1219.
20. Rodes B, Toro C, Paxinos E, et al. Differences in disease progression in a cohort of long-term non-progressors after more than 16 years of HIV-1 infection. AIDS. 2004;18:1109-1116.
21. Garbuglia AR, Salvi R, Di Caro A, et al. In vitro activation of HIV RNA expression in peripheral blood lymphocytes as a marker to predict the stability of non-progressive status in long-term survivors. AIDS. 1996;10: 17-21.
22. Birch MR, Learmont JC, Dyer WB, et al. An examination of signs of disease progression in survivors of the Sydney Blood Bank Cohort (SBBC). J Clin Virol. 2001;22:263-270.